載入...
RNA Editing with CRISPR-Cas13
Nucleic acid editing holds promise for treating genetic disease, particularly at the RNA level, where disease-relevant sequences can be rescued to yield functional protein products. Type VI CRISPR-Cas systems contain the programmable single-effector RNA-guided RNases Cas13. Here, we profile Type VI...
Na minha lista:
| 發表在: | Science |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5793859/ https://ncbi.nlm.nih.gov/pubmed/29070703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aaq0180 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|